XRTX
XORTX Therapeutics Inc
NASDAQ: XRTX · HEALTHCARE · BIOTECHNOLOGY
$2.86
+4.76% today
Updated 2026-04-30
Market cap
$4.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.80
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
XORTX Therapeutics Inc (XRTX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | $19316.00 | $19900.00 | $20439.00 | $17882.00 | $75268.00 | $141958.00 | $160660.00 | $156657.00 |
| Gross profit | — | — | — | — | $-19316.00 | $-19900.00 | $-20439.00 | $-17882.00 | $-75268.00 | $-141958.00 | $-160660.00 | $-156657.00 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — |
| R&D | — | — | — | $66367.00 | $342251.00 | $39897.00 | $277455.00 | $853124.00 | $6.49M | $2.41M | $251840.00 | $803350.00 |
| SG&A | $36922.00 | $53955.00 | $389315.00 | $380922.00 | $795652.00 | $506168.00 | $1.10M | $1.58M | $2.29M | $1.07M | $1.59M | $1.83M |
| Operating income | $-36922.00 | $-243935.00 | $-389315.00 | $-427107.00 | $-1.07M | $-565965.00 | $-1.08M | $-2.90M | $-12.43M | $-4.81M | $-5.64M | $-4.55M |
| Operating margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | $-36922.00 | $-243935.00 | $-389315.00 | $-427107.00 | $-1.07M | $-572465.00 | $-1.25M | $-2.90M | $-9.41M | $-6.47M | $-4.38M | $-4.39M |
| EBITDA margin | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | $-36922.00 | $-257940.00 | $-405339.00 | $-443884.00 | $-1.09M | $-592365.00 | $-1.27M | $-2.92M | $-9.49M | $-6.66M | $-4.54M | $-4.55M |
| Interest expense | — | — | $8625.00 | $15463.00 | $22298.00 | $37214.00 | $13512.00 | $4390.00 | $0.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-36922.00 | $-279309.00 | $-414834.00 | $-474201.00 | $-3.78M | $-629576.00 | $-1.28M | $-1.65M | $-6.99M | $-2.86M | $-4.54M | $-3.71M |
| Net income growth (YoY) | — | -656.5% | -48.5% | -14.3% | -696.3% | +83.3% | -104.0% | -28.6% | -323.0% | +59.1% | -58.7% | +18.2% |
| Profit margin | — | — | — | — | — | — | — | — | — | — | — | — |